Is Viking Therapeutics (NASDAQ:VKTX) a buy? Compare the latest price Viking Therapeutics (VKTX) K Annual Report - Feb 9th (kb). Viking Therapeutics Cash Flow Accounts. , , , , , Additional Tools for Viking Stock Analysis. When running Viking Therapeutics. Viking Therapeutics (VKTX) Stock Price, News & Analysis ; Today's Range: $ · $ ; Day Range: $ · $ ; Week Range: $ · $ The best performance in VKTX stock price from opening price to closing price (referred to as the "drift" for the day) was on Dec for a +% gain. Complete Viking Therapeutics Inc. stock information by Barron's. View real-time VKTX stock price and news, along with industry-best analysis 19,
Mar 27, - VKTX STOCK PRICE INCREASE: Viking Therapeutics Inc on increased stock price > 10% from $ to $ · Mar 12, - VKTX STOCK PRICE. Viking Therapeutics - 9 Year Stock Price History | VKTX · The all-time high Viking Therapeutics stock closing price was on February 28, · The Viking. The analyst firm set a price target for $ expecting VKTX to rise to within 12 months (a possible % upside). 29 analyst firms have reported ratings in. stock outstanding as of June 30, and December 31, The Company's The purchase price of shares of common stock that the Company elects to. VKTX Price Returns ; YTD, % ; , % ; , % ; , % ; , %. Viking Therapeutics, Inc. is expected to issue its next earnings report on 10/23/ In the previous quarter, Viking Therapeutics, Inc. reported $ . Real time Viking Therapeutics (VKTX) stock price quote, stock graph, news & analysis. The analyst firm set a price target for $ expecting VKTX to rise to within 12 months (a possible % upside). 29 analyst firms have reported ratings. Average Price Target ; High $ ; Average $ ; Low $ VKTX Earnings History ; Jul 27, , (Q2). / , % () ; Apr 27, , (Q1). / , % (). Stock analysis for Viking Therapeutics Inc (VKTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company.
Viking Therapeutics is forecast to grow earnings and revenue by % and 74% per annum respectively. EPS is expected to grow by % per annum. Return on equity. Average Price Target ; High $ ; Average $ ; Low $ We've gathered analysts' opinions on Viking Therapeutics, Inc. future price: according to them, VKTX price has a max estimate of USD and a min estimate. Viking Therapeutics Inc (VKTX) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. Discover historical prices for VKTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Viking Therapeutics, Inc. stock was issued. All information about Viking Therapeutics (VKTX) - stock price, quote chart, key statistics, dividends, company news and more. The latest Viking Therapeutics stock prices, stock quotes, news, and VKTX history to help you invest and trade smarter. Last Price. US$ ; Market Cap. US$b ; 7D. % ; 1Y. % ; Updated. 23 Aug, Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). Viking Therapeutics, Inc. NasdaqCM. REAL TIME PRICE , ,
According to Viking Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is At the end of. The highest price target for VKTX is $, while the lowest price target for VKTX is $ The average price target represents a forecasted upside of Viking Therapeutics is overvalued with Real Value of and Target Price of The main objective of Viking Therapeutics stock analysis is to. 5/10/, -$ · $, 4/19/, -$ · $, 3/28/ The current price to earnings ratio for VKTX stock is What is the. Get Viking Therapeutics Inc (zomerstorm.online) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Viking Therapeutics is forecast to grow earnings and revenue by % and 74% per annum respectively. EPS is expected to grow by % per annum. Return on equity. Viking Therapeutics - 9 Year Stock Price History | VKTX · The all-time high Viking Therapeutics stock closing price was on February 28, · The Viking. According to 9 analysts, the average rating for VKTX stock is "Strong Buy." The month stock price forecast is $, which is an increase of % from. Get Viking Therapeutics real-time stock quotes, news, price and financial Last Quarter Report. View · 31st of December Last Financial Announcement. View. According to Viking Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is At the end of. A high-level overview of Viking Therapeutics, Inc. (VKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. The best performance in VKTX stock price from opening price to closing price (referred to as the "drift" for the day) was on Dec for a +% gain. Viking Therapeutics is forecast to grow earnings and revenue by % and 74% per annum respectively. EPS is expected to grow by % per annum. Return on equity. Wall Street analysts forecast VKTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VKTX. Real time Viking Therapeutics (VKTX) stock price quote, stock graph, news & analysis. 5/10/, -$ · $, 4/19/, -$ · $, 3/28/ The current price to earnings ratio for VKTX stock is What is the. Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Viking Therapeutics is 'Strong Sell'. Based on the average yearly growth of the Viking Therapeutics stock in the last 10 years, the VKTX stock forecast for the beginning of next year is $ All information about Viking Therapeutics (VKTX) - stock price, quote chart, key statistics, dividends, company news and more. Is Viking Therapeutics (NASDAQ:VKTX) a buy? Compare the latest price Viking Therapeutics (VKTX) K Annual Report - Feb 9th · (kb). Viking Therapeutics Inc (VKTX) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. Based on our forecasts, a long-term increase is expected, the "VKTX" stock price prognosis for is USD. With a 5-year investment, the revenue. Net sales. Million USD, Released Forecast Spread, 0,00 0,00 -, 0,00 0,00 -, 0,00 0,00 -, 0,00, 2,50, 39,2. EBITDA Million USD. Complete Viking Therapeutics Inc. stock information by Barron's. View real-time VKTX stock price and news, along with industry-best analysis 19, Mar 27, - VKTX STOCK PRICE INCREASE: Viking Therapeutics Inc on increased stock price > 10% from $ to $ · Mar 12, - VKTX STOCK PRICE. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). Viking Therapeutics, Inc. NasdaqCM. REAL TIME PRICE , , Viking Therapeutics Earnings History by Quarter ; 10/26/, Q3 , ($) ; 7/27/, Q2 , ($) ; 4/27/, Q1 , ($) ; 2/9/, Q4 , ($. VKTX Earnings History ; Jul 27, , (Q2). / , % () ; Apr 27, , (Q1). / , % (). Get Viking Therapeutics Inc (VKTX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Discover historical prices for VKTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Viking Therapeutics, Inc. stock was issued. Stock analysis for Viking Therapeutics Inc (VKTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. 5-year, % ; YTD, % ; , % ; , % ; , %. Last Price. US$ ; Market Cap. US$b ; 7D. % ; 1Y. % ; Updated. 07 Sep, The 41 analysts offering price forecasts for Viking Therapeutics have a median target of , with a high estimate of and a low estimate of The lowest target is $90 and the highest is $ Please note analyst price targets are not guaranteed and could be missed completely. VKTX Analyst Ratings.
VKTX Stock (Viking Therapeutics stock) VKTX STOCK PREDICTION VKTX STOCK analysis VKTX stock news